Martin Freed
Director/Board Member at SOLID BIOSCIENCES INC.
Net worth: 30 607 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Adam Koppel | M | 54 | 7 years | |
| Ilan Ganot | M | 50 | 11 years | |
| Raj Shah | M | 46 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 7 years |
| TY Howton | M | 52 | 2 years | |
| Alexander Cumbo | M | 53 | 2 years | |
| Clare Khan | M | 72 | 3 years | |
| Ian Smith | M | 58 | 4 years | |
| Annie Ganot | F | - | 11 years | |
| Lynne Sullivan | F | 58 | 9 years | |
| Georgia Keresty | M | 62 | 3 years | |
| Sukumar Nagendran | M | 58 | 6 years | |
| Sharon Cload | M | - |
Adnexus
 Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 16 years |
| Adam Stone | M | 44 | 9 years | |
| David J. Caponera | M | 67 | 5 years | |
| Allison Bogosian | F | - | 3 years | |
| Shuli Kulak | M | - | - | |
| Jenny Marlowe | M | 47 | 1 years | |
| Paul Herzich | M | 46 | 2 years | |
| Jessie Hanrahan | M | 47 | 2 years | |
| Kevin Tan | M | 46 | 1 years | |
| Ulrich Christian Otte | M | - | 3 years | |
| Jamie Haney | F | - | 3 years | |
| Thomas Haagen | M | 58 | 3 years | |
| Michael Inbar | M | - | 3 years | |
| Alison Kessler | F | - | 4 years | |
| Robert D. Ciappenelli | M | 57 | 5 years | |
| Gabriel Brooks | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Joel Schneider | M | 39 | 8 years | |
| Linda Higgins | M | 62 |
InteKrin Therapeutics, Inc.
 InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Glenn Batchelder | M | 63 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Douglas Fambrough | M | 55 | 14 years | |
| Stephen DiPalma | M | 66 | 2 years | |
| Robert Morales | M | 57 | 7 years | |
| Matthew Bennett Arnold | M | 55 | 8 years | |
| Mark Iwicki | M | 57 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Gilad D. Hayeem | M | 57 | 5 years | |
| Richard Batycky | M | 56 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | 5 years |
| J. Buchi | M | 69 | 3 years | |
| Andrea Franz | F | 62 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Caitlin Lowie | F | - | 1 years | |
| David H. Smith | M | - |
University of Delaware
| 6 years |
| John Mendlein | M | 64 |
Adnexus
Adnexus Pharmaceuticals: MajorHealth Technology Adnexus engages in the development of Adnectins biologics and medicines in the United States. The company was founded by Frank D. Lee on September 16, 2002 and is headquartered in Waltham, MA. | 3 years |
| Josiah Craver | M | - | 3 years | |
| Dennis Langer | M | 73 | 12 years | |
| Kristen K. Sheppard | F | - | 1 years | |
| Stephen J. Hoffman | M | 70 | 14 years | |
| Peter Kolchinsky | M | 47 | 6 years | |
| Michael Nazak | M | 66 |
InteKrin Therapeutics, Inc.
InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA. | - |
| Bill Lundberg | M | 60 |
Taligen Therapeutics, Inc.
 Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | 2 years |
| Jennifer Ziolkowski | F | 50 | 4 years | |
| Marc Kozin | M | 62 | 2 years | |
| Lynette Herscha | F | 52 | - | |
| Mark Stutman | M | - |
University of Delaware
| 6 years |
| Cynthia Smith | F | 55 | 3 years | |
| Lee Michael Ahlstrom | M | 56 |
University of Delaware
| 6 years |
| Erin Brennan | M | 53 | 1 years | |
| Cheri D. Mitchell | F | - |
University of Delaware
| 6 years |
| Tammy Reilly | F | 61 |
University of Delaware
| 7 years |
| Paul J. Miller | M | - |
University of Delaware
| 6 years |
| John Green | M | 43 | 6 years | |
| Bruce Peacock | M | 72 | 4 years | |
| David Michael Madden | M | 61 | 10 years | |
| Ling Zeng | F | 55 | 2 years | |
| Bill Hassiepen | M | - |
University of Delaware
| 9 years |
| Brian Halak | M | 52 | 9 years | |
| Donald Hayden | M | 68 | 10 years | |
| Stephen Doberstein | M | 65 | 1 years | |
| Anna Protopapas | F | 59 | 2 years | |
| Andrey Zarur | M | 54 | 7 years | |
| Ashish Diwanji | M | - |
University of Delaware
| 5 years |
| Patrick M. Gray | M | 75 | 2 years | |
| Richard Stevenson | M | - |
University of Delaware
| 4 years |
| Mamoru Tsuru | M | 66 |
University of Delaware
| 3 years |
| Michael McGurk | M | - |
University of Delaware
| 4 years |
| Stephanie McCormick | F | - |
University of Delaware
| 4 years |
| James Volk | M | 61 |
University of Delaware
| 4 years |
| John E. Drastal | M | - |
University of Delaware
| 4 years |
| Mark McDonough | M | - |
University of Delaware
| 4 years |
| Simon Godwin | M | - |
University of Delaware
| 5 years |
| Barry Allen Schwartz | M | - |
University of Delaware
| 4 years |
| David Peter Przywara | M | 56 |
University of Delaware
| 5 years |
| Steven R. Mast | M | - |
University of Delaware
| 4 years |
| Bruce Robertson | M | 61 |
University of Delaware
| 4 years |
| James G. Reindl | M | 65 |
University of Delaware
| 4 years |
| Doug Kugler | M | 63 |
University of Delaware
| 4 years |
| Jonathan Frederic Kolle | M | - |
University of Delaware
| 4 years |
| Christine Frampton Williams | F | 59 |
University of Delaware
| 4 years |
| Ryan Laurence Worst | M | - |
University of Delaware
| 4 years |
| Nat C. Brinn | M | - |
University of Delaware
| 4 years |
| Tracey Brown | F | 56 |
University of Delaware
| 4 years |
| Jeffrey S. Hughes | M | 62 |
University of Delaware
| 4 years |
| David J. Freschman | M | - |
University of Delaware
| 4 years |
| Craig Stuart Hetherington | M | - |
University of Delaware
| 4 years |
| Maureen Cottrell | F | - |
University of Delaware
| 4 years |
| Jack Baldwin | M | - |
University of Delaware
| 4 years |
| Todd James Henry | M | - |
University of Delaware
| 4 years |
| Ronald Bruehlman | M | 63 |
University of Delaware
| 4 years |
| Bryan Shinn | M | 62 |
University of Delaware
| 4 years |
| Greg Scheu | M | 61 |
University of Delaware
| 4 years |
| Doug Hopkins | M | - |
University of Delaware
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Martin Freed
- Personal Network